1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Candida Infection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ananthaswamy, HN; Bucana, C; Byrne, S; Matsumura, Y; Nghiem, DX; Ullrich, SE; Walterscheid, JP; Wolf, P | 1 |
| Choi, EK; Choi, IW; Choi, JH; Han, SJ; Im, SY; Kim, KJ; Ko, HM; Park, SJ | 1 |
| Cho, KO; Choi, IW; Choi, JH; Im, SY; Kim, HA; Kim, KJ; Kim, SH; Ko, HM; Oh, SH | 1 |
| Choi, JH; Chun, SB; Ha, TY; Han, SJ; Im, SY; Ko, HM; Lee, HK | 1 |
| Choi, JH; Chun, SB; Han, SS; Im, SY; Kim, JW; Ko, HM; Lee, HK | 1 |
| Kalkanci, A; Kuştimur, S; Timlioğlu, O; Uluoğlu, C | 1 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Candida Infection
| Article | Year |
|---|---|
Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.
Topics: Animals; Apoptosis; Candida albicans; Candidiasis; Combined Modality Therapy; Female; Ficusin; Humans; Hypersensitivity, Delayed; Immune Tolerance; Immunosuppression Therapy; Inflammation; Interleukin-10; Lymphoma, T-Cell, Cutaneous; Male; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Psoriasis; PUVA Therapy; Receptors, G-Protein-Coupled; Signal Transduction | 2006 |
Impairment of p38 MAPK-mediated cytosolic phospholipase A2 activation in the kidneys is associated with pathogenicity of Candida albicans.
Topics: Animals; Candida albicans; Candidiasis; Enzyme Inhibitors; Female; Gene Expression Regulation; Kidney Diseases; Mice; Mice, Inbred BALB C; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Phosphorylation; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Virulence | 2007 |
Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis.
Topics: Animals; Candida albicans; Candidiasis; Female; Guanidines; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Neutrophils; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
A protective role of platelet-activating factor in murine candidiasis.
Topics: Animals; Candidiasis; Female; Mice; Mice, Inbred BALB C; Platelet Activating Factor; RNA, Messenger; Tumor Necrosis Factor-alpha | 1997 |
Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans.
Topics: Adjuvants, Immunologic; Animals; Candida albicans; Candidiasis; Disease Susceptibility; Female; Immune Sera; Immunity, Cellular; Immunity, Innate; Injections, Intraperitoneal; Kidney; Lung; Mice; Mice, Inbred BALB C; NF-kappa B; Organ Specificity; Platelet Activating Factor; Spleen; Tumor Necrosis Factor-alpha | 2001 |
The role of tumour necrosis factor-alpha (TNF-alpha) and platelet-activating factor (PAF) interaction on murine candidosis.
Topics: Animals; Candidiasis; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Tumor Necrosis Factor-alpha | 2002 |